Breast health in developing countries

References

• http:/data.worldbank.org/country
   Google Scholar
• http://globocan.iarc.fr
   Google Scholar
• Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008;9:730–56
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 2007;356:1670–4
   PubMed Web of Science ®Google Scholar
• Porter P. ‘Westernizing’ women’s risks? Breast cancer in lower-income countries. N Engl J Med 2008;358:213–16
   PubMed Web of Science ®Google Scholar
• Seow A, Duffy SW, McGee MA, Lee J, Lee HP. Breast cancer in Singapore: trends in incidence 1968–1992. Int J Epidemiol 1996;25:40–5
   PubMed Web of Science ®Google Scholar
• Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011;378:1461–84
   PubMed Web of Science ®Google Scholar
• http://data.un.org/Data.aspx?d = PopDiv&f = variableID%3A41
   Google Scholar
• Ghiasvand R, Adami HO, Harirchi I, Akrami R, Zendehdel K. Higher incidence of premenopausal breast cancer in less developed countries; myth or truth? BMC Cancer 2014;14:343
   PubMed Web of Science ®Google Scholar
• Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiol 2009;33:315–18
   PubMed Web of Science ®Google Scholar
• Yip CH, Taib NA. Challenges in the management of breast cancer in low- and middle-income countries. Future Oncol 2012;8:1575–83
   PubMed Web of Science ®Google Scholar
• Taib NA, Yip CH, Low WY. A grounded explanation of why women present with advanced breast cancer. World J Surg 2013;38:1676–84
   Web of Science ®Google Scholar
• Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS. Spectrum of breast cancer in Asian women. World J Surg 2007;31:1031–40
   PubMed Web of Science ®Google Scholar
• Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer 2013; 108:2205–40
   PubMed Web of Science ®Google Scholar
• Burton RC, Bell RJ, Thiagarajah G, Stevenson C. Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991. Breast Cancer Res Treat 2012;131:949–55
   PubMed Web of Science ®Google Scholar
• Biller-Andorno N, Juni P. Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med 2014;370:1965–7
   PubMed Web of Science ®Google Scholar
• Gotzsche PC, Jorgensen KJ. The benefits and harms of breast cancer screening. Lancet 2013;381:799
   PubMed Web of Science ®Google Scholar
• Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002;94:1445–57
   PubMed Web of Science ®Google Scholar
• Mittra I, Mishra GA, Singh S, et al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer 2010;126:976–84
   PubMed Web of Science ®Google Scholar
• Yip CH, Smith RA, Anderson BO, et al. Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer 2008;113(8 Suppl):2244–56
   PubMed Web of Science ®Google Scholar
• Pisani P, Parkin DM, Ngelangel C, et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer 2006;118:149–54
   PubMed Web of Science ®Google Scholar
• Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition, summary document. Ann Oncol 2008;19:614–22
   Google Scholar
• Eniu A, Carlson RW, Aziz Z, et al. Breast cancer in limited- resource countries: treatment and allocation of resources. Breast J 2006;12(Suppl 1):S38–53
   Google Scholar
• Datta NR, Samiei M, Bodis S. Radiation therapy infrastructure and human resources in low- and middle-income countries: present status and projections for 2020. Int J Radiat Oncol Biol Physics 2014;89:448–57
   PubMed Web of Science ®Google Scholar
• Shyyan R, Masood S, Badwe RA, et al. Breast cancer in limited-resource countries: diagnosis and pathology. Breast J 2006; 12(Suppl 1):S27–37
   Google Scholar
• Knaul FM, Shulman LN, Gralow J, Quick J, Bhadelia A, Frenk J. Improving pathology for better cancer care and control in countries of low and middle income. Lancet 2012; 379:2052
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687–717
   PubMed Web of Science ®Google Scholar
• http://www.who.int/medicines/publications/essentialmedicines/en/l
   Google Scholar
• El Saghir NS, Adebamowo CA, Anderson BO, et al. Breast cancer management in low resource countries (LRCs): consensus statement from the Breast Health Global Initiative. Breast 2011;20(Suppl 2):S3–11
   Google Scholar
• Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005;353:1659–72
   PubMed Web of Science ®Google Scholar
• Anderson BO, Shyyan R, Eniu A, et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J 2006;12(Suppl 1):S3–15
   Google Scholar
• Ganz PA, Yip CH, Gralow JR, et al. Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast 2013; 22:606–15
   Google Scholar
• Ginsburg OM. Breast and cervical cancer control in low and mddle-income countries: Human rights meet sound health policy. J Cancer Policy 2013;1:e35–41
   Google Scholar
• Azenha G, Bass LP, Caleffi M, et al. The role of breast cancer civil society in different resource settings. Breast 2011;20(Suppl 2):S81–7
   Google Scholar
• Harford J, Azavedo E, Fischietto M, Breast Health Global Initiative Healthcare Systems. Guideline implementation for breast healthcare in low- and middle-income countries: breast healthcare program resource allocation. Cancer 2008;113(8 Suppl): 2282–96
   PubMed Web of Science ®Google Scholar
• Bhoo-Pathy N, Yip CH, Hartman M, et al. Breast cancer research in Asia: adopt or adapt Western knowledge? Eur J Cancer 2013;49:703–9
   PubMed Web of Science ®Google Scholar
• Love RR. Defining a global research agenda for breast cancer. Cancer 2008;113(8 Suppl):2366–71
   PubMed Web of Science ®Google Scholar
• Devi CR, Tang TS, Corbex M. Incidence and risk factors for breast cancer subtypes in three distinct South-East Asian ethnic groups: Chinese, Malay and natives of Sarawak, Malaysia. Int J Cancer 2012;131:2869–77
   PubMed Web of Science ®Google Scholar
• Amirikia KC, Mills P, Bush J, Newman LA. Higher population-based incidence rates of triple-negative breast cancer among young African-American women: Implications for breast cancer screening recommendations. Cancer 2011;117:2747–53
   PubMed Web of Science ®Google Scholar
• Anderson KN, Schwab RB, Martinez ME. Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat 2014;144:1–10
   PubMed Web of Science ®Google Scholar
• Province MA, Goetz MP, Brauch H, et al. CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations. Clin Pharmacol Ther 2014;95:216–27
   PubMed Web of Science ®Google Scholar
• Hoskins JM, Carey LA, McLeod HL. CYP2D6 and tamoxifen: DNA matters in breast cancer. Nature Rev Cancer 2009;9: 576–86
   PubMed Web of Science ®Google Scholar
• Ma B, Yeo W, Hui P, Ho WM, Johnson PJ. Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer – a retrospective review of Chinese patients and comparison with an historic Western series. Radiother Oncol 2002;62:185–9
   PubMed Web of Science ®Google Scholar
• Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010;376:1186–93
   PubMed Web of Science ®Google Scholar
• Lim GC, Aina EN, Cheah SK, et al. Closing the global cancer divide – performance of breast cancer care services in a middle income developing country. BMC Cancer 2014;14:212
   PubMedGoogle Scholar